Clinical Trials Browser

Expanded_access × Myasthenia Gravis × efgartigimod alfa × Clear all

NCT04777734 2022-04-29

Efgartigimod Expanded Access for Generalized Myasthenia Gravis

Approved for marketing

Myasthenia Gravis